Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Sleep Apnea Returns Rapidly When CPAP Is Stopped

By HospiMedica International staff writers
Posted on 13 Sep 2011
Obstructive sleep apnea (OSA) and its associated complications recur rapidly after discontinuation of continuous positive airway pressure (CPAP), according to a new study.

Researchers at University Hospital Zurich (Switzerland) conducted a randomized controlled trial involving 41 OSA patients on CPAP to determine the effects of CPAP withdrawal. More...
The patients were randomized to either continue CPAP or undergo CPAP withdrawal (subtherapeutic CPAP) for a period of two weeks. Polysomnography, sleepiness, psychomotor performance, endothelial function, blood pressure (BP), heart rate (HR), urinary catecholamines, blood markers of systemic inflammation, and metabolism were assessed.

The results showed that CPAP-withdrawal lead to a recurrence of OSA within a few days, together with a return of subjective sleepiness, but were not associated with significant deterioration of psychomotor performance within the two weeks. CPAP withdrawal was associated with a significant increase in morning systolic BP, morning diastolic BP, and morning heart rate. Endothelial function decreased significantly in the CPAP-withdrawal group compared to therapeutic CPAP. CPAP withdrawal was also associated with an increase in urinary catecholamines, but did not lead to an increase in markers of systemic inflammation, insulin resistance, or blood lipids. The study was published ahead of print on August 11, 2011, in the American Journal of Respiratory and Critical Care Medicine.

“We found that CPAP withdrawal was associated with a return of OSA by the first night,” said lead author Malcolm Kohler, MD, of University Hospital Zurich in Switzerland, and colleagues of the Sleep Disorders Center and Pulmonary Division. “Withdrawal usually leads to a rapid recurrence of OSA, a return of subjective sleepiness and is associated with impaired endothelial function, increased urinary catecholamines, blood pressure, and heart rate.”

A continuous positive airway pressure (CPAP) device delivers a stream of compressed air to a nose mask, keeping the airway open under air pressure so that unobstructed breathing becomes possible, thereby reducing, or preventing apneas and hypopneas. It is important to understand that it is the air pressure, and not the movement of the air, that prevents the apneas; this has the additional benefit of reducing or eliminating the extremely loud snoring that sometimes accompanies OSA. Given that it is a chronic health issue, ongoing care is usually needed to maintain CPAP therapy.

Related Links:

University Hospital Zurich



Gold Member
12-Channel ECG
CM1200B
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Bipolar Coagulation Generator
Aesculap
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.